Calidi Biotherapeutics, Inc. (CLDI) › RevenueCalidi Biotherapeutics, Inc. (CLDI) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2022$45.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share